Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,186 | 459 | 95.9% |
| Education | $262.47 | 4 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $898.44 | 48 | $0 (2024) |
| Amgen Inc. | $679.49 | 39 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $481.95 | 40 | $0 (2023) |
| ABBVIE INC. | $378.93 | 41 | $0 (2024) |
| Allergan, Inc. | $377.55 | 47 | $0 (2020) |
| Astellas Pharma US Inc | $310.30 | 7 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $272.58 | 37 | $0 (2023) |
| PFIZER INC. | $267.67 | 18 | $0 (2023) |
| GlaxoSmithKline, LLC. | $256.37 | 19 | $0 (2023) |
| Novo Nordisk Inc | $208.82 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.92 | 10 | Organon Llc ($29.69) |
| 2023 | $1,276 | 70 | AstraZeneca Pharmaceuticals LP ($395.87) |
| 2022 | $1,452 | 121 | AstraZeneca Pharmaceuticals LP ($263.14) |
| 2021 | $1,812 | 138 | AbbVie Inc. ($273.17) |
| 2020 | $715.87 | 50 | Allergan, Inc. ($183.32) |
| 2019 | $399.95 | 20 | Amgen Inc. ($191.77) |
| 2018 | $203.64 | 14 | Amgen Inc. ($42.28) |
| 2017 | $375.36 | 40 | Allergan Inc. ($126.44) |
All Payment Transactions
463 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 08/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.93 | General |
| 06/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Immunology | ||||||
| 05/07/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: ANTIBIOTIC | ||||||
| 03/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Oncology | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Respiratory | ||||||
| 11/30/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Biological | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.30 | General |
| Category: Cardiovascular | ||||||
| 10/11/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: INSOMNIA | ||||||
| 09/19/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Bone Health | ||||||
| 09/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Central Nervous System | ||||||
| 09/06/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardio-renal | ||||||
| 08/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 4,181 | 25,579 | $757,138 | $249,929 |
| 2022 | 33 | 5,446 | 7,889 | $867,688 | $240,102 |
| 2021 | 39 | 6,022 | 8,604 | $523,389 | $277,224 |
| 2020 | 38 | 5,934 | 8,140 | $476,972 | $223,312 |
All Medicare Procedures & Services
149 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 406 | 603 | $153,096 | $50,462 | 33.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 335 | 335 | $91,726 | $41,238 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 333 | 703 | $123,823 | $38,818 | 31.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 105 | 105 | $41,160 | $29,703 | 72.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 113 | 113 | $10,283 | $8,128 | 79.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 56 | 81 | $23,014 | $7,884 | 34.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 122 | $21,968 | $7,596 | 34.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 34 | 184 | $14,562 | $6,911 | 47.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 36 | 41 | $17,154 | $6,301 | 36.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 34 | 34 | $12,558 | $5,486 | 43.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 49 | 66 | $11,002 | $4,179 | 38.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 256 | 301 | $39,130 | $3,938 | 10.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 63 | 400 | $17,628 | $3,719 | 21.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 48 | 73 | $10,512 | $3,572 | 34.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 109 | 109 | $6,322 | $3,233 | 51.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 262 | 312 | $31,200 | $3,229 | 10.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 444 | 517 | $11,374 | $2,887 | 25.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 96 | 96 | $5,568 | $2,847 | 51.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 254 | 324 | $25,920 | $2,466 | 9.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 70 | 71 | $8,520 | $2,060 | 24.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 171 | 211 | $14,111 | $2,009 | 14.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 120 | 120 | $14,400 | $1,975 | 13.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,940 | $1,769 | 44.9% |
| 83735 | Magnesium level | Office | 2023 | 239 | 264 | $7,920 | $1,734 | 21.9% |
| 86318 | Test for detection of infectious agent antibody, qualitative or semiquantitative | Office | 2023 | 63 | 73 | $5,694 | $1,294 | 22.7% |
About Dr. David Ade, MD
Dr. David Ade, MD is a Internal Medicine healthcare provider based in Moline, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972589042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ade, MD has received a total of $6,449 in payments from pharmaceutical and medical device companies, with $212.92 received in 2024. These payments were reported across 463 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($6,186).
As a Medicare-enrolled provider, Ade has provided services to 21,583 Medicare beneficiaries, totaling 50,212 services with total Medicare billing of $990,567. Data is available for 4 years (2020–2023), covering 149 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Moline, IL
- Active Since 12/20/2005
- Last Updated 11/28/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972589042
Products in Payments
- FARXIGA (Drug) $425.57
- EVENITY (Biological) $256.56
- Linzess (Drug) $254.38
- ELIQUIS (Drug) $236.25
- UBRELVY (Drug) $224.10
- VRAYLAR (Drug) $216.52
- Aimovig (Biological) $200.61
- BREZTRI (Drug) $190.56
- JARDIANCE (Drug) $178.26
- TRELEGY ELLIPTA (Drug) $171.86
- Kerendia (Drug) $168.33
- XARELTO (Drug) $148.25
- Vascepa (Drug) $146.96
- ZENPEP (Drug) $142.21
- OFEV (Drug) $134.50
- XIFAXAN (Drug) $134.46
- LINZESS (Drug) $117.09
- Prolia (Biological) $116.33
- Repatha (Biological) $105.99
- Livalo (Drug) $91.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Moline
Dr. Phanicharan Sistla, M.d, M.D
Internal Medicine — Payments: $15,060
Thomas Ade, Md, MD
Internal Medicine — Payments: $14,807
Rajiv Mallik, M.d, M.D
Internal Medicine — Payments: $13,973
Dr. Harish Patlolla, M.d, M.D
Internal Medicine — Payments: $13,789
Brian Cady, Md, MD
Internal Medicine — Payments: $6,765
Dr. Namrata Mallik, Md, MD
Internal Medicine — Payments: $5,036